Cargando…
Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine
BACKGROUND: Cancer stem cells (CSCs) are considered responsible for the recurrence and chemoresistance of cancer. Dysregulated autophagy is highly prevalent in many types of cancer including pancreatic cancer and has been implicated in cytoprotection and tumor promotion. This study aimed to investig...
Autores principales: | Yang, Ming-Chen, Wang, Hao-Chen, Hou, Ya-Chin, Tung, Hui-Ling, Chiu, Tai-Jan, Shan, Yan-Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603764/ https://www.ncbi.nlm.nih.gov/pubmed/26458814 http://dx.doi.org/10.1186/s12943-015-0449-3 |
Ejemplares similares
-
Iron Oxide Nanoparticles as Autophagy Intervention Agents Suppress Hepatoma Growth by Enhancing Tumoricidal Autophagy
por: Xie, Yuexia, et al.
Publicado: (2020) -
Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
por: Wang, Sheng, et al.
Publicado: (2021) -
Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
por: Hou, Ya-Chin, et al.
Publicado: (2014) -
Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer
por: Park, Ji Min, et al.
Publicado: (2022) -
Reciprocal Complementation of the Tumoricidal Effects of Radiation and Natural Killer Cells
por: Yang, Kai-Lin, et al.
Publicado: (2013)